Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
September 20, 2022
0Patent Application Number
163449740
Date Filed
November 1, 2017
0Patent Citations
Patent Primary Examiner
CD47− disease cells such as cancer cells are treated using a combination of CD47 blockade drug and a proteasome inhibitor. The anti-cancer effect of one drug enhances the 5 anti-cancer effect of the other. Specific combinations include SIRPαFc as CD47 blockade drug, and one of bortezomib, ixazomib and carfilzomib as proteasome inhibitor. These combinations are useful particularly to treat blood cancers including lymphomas, leukemias and myelomas.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
